ask="37.99"
ask_size="100"
average_daily_volume="1390840"
bid="24.45"
bid_size="100"
book_value="11.83"
change="+0.21"
change_from_200_day_moving_average="-16.59"
change_from_50_day_moving_average="-3.16"
change_from_52_week_high="-42.28"
change_From_52_week_low="6.45"
change_in_percent="+0.56%"
close="37.83"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.82"
eps_estimate_next_quarter="-1.33"
eps_estimate_next_year="-5.05"
ex_dividend_date="N/A"
float_shares="70877000"
high="38.25"
high_52_weeks="80.11"
last_trade_date="1/25/2017"
last_trade_price="37.83"
last_trade_size="23305"
last_trade_time="4:00pm"
low="37.27"
low_52_weeks="31.38"
market_capitalization="3.25B"
moving_average_200_day="54.42"
moving_average_50_day="40.99"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="63.57"
open="37.93"
pe_ratio="N/A"
peg_ratio="-0.17"
percent_change_from_200_day_moving_average="-30.48%"
percent_change_from_50_day_moving_average="-7.71%"
percent_change_from_52_week_high="-52.78%"
percent_change_from_52_week_low="+20.55%"
previous_close="37.62"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.18"
price_per_sales="86.65"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="5.47"
stock_exchange="NMS"
symbol="ALNY"
volume="521521"
weeks_range_52="31.38 - 80.11"
